tiprankstipranks
MiniMed Group, Inc. (MMED)
NASDAQ:MMED
US Market
MMED
MiniMed Group, Inc.
RESEARCH TOOLSreports

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

33 Followers
See the Price Targets and Ratings of:

MMED Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
MiniMed
Group, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MMED Stock 12 Month Forecast

Average Price Target

$21.55
▲(44.44% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for MiniMed Group, Inc. in the last 3 months. The average price target is $21.55 with a high forecast of $27.00 and a low forecast of $14.00. The average price target represents a 44.44% change from the last price of $14.92.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"$13","28":"$28","16.75":"$16.75","20.5":"$20.5","24.25":"$24.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,16.75,20.5,24.25,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.49,19.144615384615385,19.799230769230768,20.453846153846154,21.108461538461537,21.763076923076923,22.417692307692306,23.072307692307692,23.726923076923075,24.38153846153846,25.036153846153844,25.69076923076923,26.345384615384617,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.49,18.725384615384613,18.96076923076923,19.196153846153845,19.431538461538462,19.666923076923077,19.90230769230769,20.13769230769231,20.373076923076923,20.60846153846154,20.843846153846155,21.07923076923077,21.314615384615387,{"y":21.55,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.49,18.144615384615385,17.799230769230768,17.453846153846154,17.108461538461537,16.763076923076923,16.417692307692306,16.072307692307692,15.726923076923075,15.381538461538462,15.036153846153844,14.69076923076923,14.345384615384615,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.49,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$27.00Average Price Target$21.55Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MMED
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$19
Buy
27.35%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at Morgan StanleyMiniMed initiated with an Overweight at Morgan Stanley
William Blair Analyst forecast on MMED
Steven Lichtman
William Blair
William Blair
$14
Buy
-6.17%
Downside
Initiated
03/31/26
MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair
Deutsche Bank Analyst forecast on MMED
Pito Chickering
Deutsche Bank
Deutsche Bank
$20
Buy
34.05%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank
Mizuho Securities Analyst forecast on MMED
Anthony Petrone
Mizuho Securities
Mizuho Securities
$21
Buy
40.75%
Upside
Initiated
03/31/26
MiniMed initiated with an Outperform at MizuhoMiniMed initiated with an Outperform at Mizuho
Barclays Analyst forecast on MMED
Matt Miksic
Barclays
Barclays
$26
Buy
74.26%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays
Citi Analyst forecast on MMED
Joanne Wuensch
Citi
Citi
$23
Buy
54.16%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at CitiMiniMed initiated with a Buy at Citi
Bank of America Securities Analyst forecast on MMED
Travis Steed
Bank of America Securities
Bank of America Securities
$27
Buy
80.97%
Upside
Initiated
03/31/26
MiniMed: Capturing Post–Spin-Off Growth Inflection With Integrated Pump/CGM Platform and Attractive Valuation
Wells Fargo Analyst forecast on MMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$26
Buy
74.26%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at Wells FargoMiniMed initiated with an Overweight at Wells Fargo
Evercore ISI Analyst forecast on MMED
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$20
Buy
34.05%
Upside
Initiated
03/31/26
MiniMed initiated with an Outperform at Evercore ISIMiniMed initiated with an Outperform at Evercore ISI
Goldman Sachs Analyst forecast on MMED
David Roman
Goldman Sachs
Goldman Sachs
―
Buy
―
Initiated
03/31/26
MiniMed initiated with a Buy at Goldman SachsMiniMed initiated with a Buy at Goldman Sachs
Piper Sandler Analyst forecast on MMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$16
Hold
7.24%
Upside
Initiated
03/31/26
Balancing Franchise Strength with Execution Risks: Why MiniMed Merits a Hold Rating
BTIG Analyst forecast on MMED
Marie Thibault
BTIG
BTIG
$25
Buy
67.56%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at BTIGMiniMed initiated with a Buy at BTIG
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MMED
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$19
Buy
27.35%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at Morgan StanleyMiniMed initiated with an Overweight at Morgan Stanley
William Blair Analyst forecast on MMED
Steven Lichtman
William Blair
William Blair
$14
Buy
-6.17%
Downside
Initiated
03/31/26
MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair
Deutsche Bank Analyst forecast on MMED
Pito Chickering
Deutsche Bank
Deutsche Bank
$20
Buy
34.05%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank
Mizuho Securities Analyst forecast on MMED
Anthony Petrone
Mizuho Securities
Mizuho Securities
$21
Buy
40.75%
Upside
Initiated
03/31/26
MiniMed initiated with an Outperform at MizuhoMiniMed initiated with an Outperform at Mizuho
Barclays Analyst forecast on MMED
Matt Miksic
Barclays
Barclays
$26
Buy
74.26%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays
Citi Analyst forecast on MMED
Joanne Wuensch
Citi
Citi
$23
Buy
54.16%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at CitiMiniMed initiated with a Buy at Citi
Bank of America Securities Analyst forecast on MMED
Travis Steed
Bank of America Securities
Bank of America Securities
$27
Buy
80.97%
Upside
Initiated
03/31/26
MiniMed: Capturing Post–Spin-Off Growth Inflection With Integrated Pump/CGM Platform and Attractive Valuation
Wells Fargo Analyst forecast on MMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$26
Buy
74.26%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at Wells FargoMiniMed initiated with an Overweight at Wells Fargo
Evercore ISI Analyst forecast on MMED
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$20
Buy
34.05%
Upside
Initiated
03/31/26
MiniMed initiated with an Outperform at Evercore ISIMiniMed initiated with an Outperform at Evercore ISI
Goldman Sachs Analyst forecast on MMED
David Roman
Goldman Sachs
Goldman Sachs
―
Buy
―
Initiated
03/31/26
MiniMed initiated with a Buy at Goldman SachsMiniMed initiated with a Buy at Goldman Sachs
Piper Sandler Analyst forecast on MMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$16
Hold
7.24%
Upside
Initiated
03/31/26
Balancing Franchise Strength with Execution Risks: Why MiniMed Merits a Hold Rating
BTIG Analyst forecast on MMED
Marie Thibault
BTIG
BTIG
$25
Buy
67.56%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at BTIGMiniMed initiated with a Buy at BTIG
Stocks with the Highest Top Analyst Consensus in the General Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

MMED Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
5
Buy
0
0
0
0
6
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
12
In the current month, MMED has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 21.55.
Each month's total comprises the sum of three months' worth of ratings.

MMED Financial Forecast

No data currently available

MMED Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

MMED Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

MMED Stock Forecast FAQ

What is MMED’s average 12-month price target, according to analysts?
Based on analyst ratings, MiniMed Group, Inc.’s 12-month average price target is 21.55.
    What is MMED’s upside potential, based on the analysts’ average price target?
    MiniMed Group, Inc. has 44.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MMED a Buy, Sell or Hold?
          MiniMed Group, Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is MiniMed Group, Inc.’s price target?
            The average price target for MiniMed Group, Inc. is 21.55. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $27.00 ,the lowest forecast is $14.00. The average price target represents 44.44% Increase from the current price of $14.92.
              What do analysts say about MiniMed Group, Inc.?
              MiniMed Group, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of MMED?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.